Latest News and Press Releases

Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients

Dublin, May 12, 2025 (GLOBE NEWSWIRE) -- The "Imfinzi (durvalumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Gemcitabine Hydrochloride Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.The pancreatic cancer drug pipeline analysis...

Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Gemcitabine Hydrochloride - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Muscle Invasive Bladder cancer- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Muscle Invasive Bladder...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...

Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) --...

Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The pancreatic cancer drugs market size...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...